Zhonglin Hao - University of Kentucky

800 Rose Street
40536 Lexington
United States

Education/Academic qualification

Post Doctoral Fellow, Emory University

2010

Residency, Mercer University

2007

Doctor of Philosophy, University Of Tokyo

1998

Master of Science, Tianjin University

1989

Doctor of Medicine, Inner Mongolia Normal University Huhho

1986

14 Finished
14 Active

24-LUN-138-BNT-PMC (BNT116-01): First-in-Human, Open label, Phase I Dose Confirmation Trial Evaluating The Safety, Tolerability, and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-Small Cell Lung Cancer
Hao, Z. (PI)
BioNTech SE
11/25/24 → 11/25/26
Project: Research project
24-LUN-139-BNT (BNT327-01): A Phase II, Multi-site, Open-label, Parallel Group Trial of BNT327 in Combination with Chemotherapy for Participants with Untreated Extensive-Stage Small-Cell Lung Cancer and Participants with Previously Treated Small-Cell Lung
Hao, Z. (PI)
BioNTech SE
11/25/24 → 11/25/26
Project: Research project
24-LUN-140-DS-PMC (DS3201-330): A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial of Valemetostat Tosylate Plus Pembrolizumab vs Pembrolizumab Alone in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer Whose
Hao, Z. (PI)
Daiichi Sankyo Incorporated
11/12/24 → 11/12/26
Project: Research project
23-LUN-134-OC4(Preserve-003): Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors
Hao, Z. (PI)
OncoC4 Incorporated
1/8/24 → 1/8/26
Project: Research project
Pdcd4-Rictor Interaction in Suppression of Lung Tumorigenesis
Yang, H.-S. (PI), Chen, L. (CoI), Fan, W.-M. (CoI), Hao, Z. (CoI), Lee, E. (CoI), Liu, X. (CoI) & Zhan, C.-G. (CoI)
National Cancer Institute
9/20/23 → 8/31/28
Project: Research project